Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Statistics

Total Valuation

CRVS has a market cap or net worth of $1.18 billion. The enterprise value is $1.13 billion.

Market Cap	1.18B
Enterprise Value	1.13B

Important Dates

The last earnings date was Thursday, March 12, 2026, after market close.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

CRVS has 83.99 million shares outstanding. The number of shares has increased by 30.76% in one year.

Current Share Class	83.99M
Shares Outstanding	83.99M
Shares Change (YoY)	+30.76%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	2.35%
Owned by Institutions (%)	47.27%
Float	72.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	17.18
P/TBV Ratio	19.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.21, with a Debt / Equity ratio of 0.02.

Current Ratio	6.21
Quick Ratio	6.09
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.60% and return on invested capital (ROIC) is -56.05%.

Return on Equity (ROE)	-32.60%
Return on Assets (ROA)	-38.36%
Return on Invested Capital (ROIC)	-56.05%
Return on Capital Employed (ROCE)	-69.60%
Weighted Average Cost of Capital (WACC)	8.89%
Revenue Per Employee	n/a
Profits Per Employee	-$413,054
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +198.31% in the last 52 weeks. The beta is 0.84, so CRVS's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	+198.31%
50-Day Moving Average	16.69
200-Day Moving Average	8.81
Relative Strength Index (RSI)	35.16
Average Volume (20 Days)	1,225,489

Short Selling Information

The latest short interest is 16.01 million, so 19.06% of the outstanding shares have been sold short.

Short Interest	16.01M
Short Previous Month	14.88M
Short % of Shares Out	19.06%
Short % of Float	22.17%
Short Ratio (days to cover)	9.82

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.97M
Pretax Income	-15.28M
Net Income	-15.28M
EBITDA	-42.87M
EBIT	-42.97M
Earnings Per Share (EPS)	-$0.53

Balance Sheet

The company has $56.75 million in cash and $937,000 in debt, with a net cash position of $55.81 million or $0.66 per share.

Cash & Cash Equivalents	56.75M
Total Debt	937,000
Net Cash	55.81M
Net Cash Per Share	$0.66
Equity (Book Value)	61.21M
Book Value Per Share	0.82
Working Capital	48.83M

Cash Flow

In the last 12 months, operating cash flow was -$32.80 million and capital expenditures -$174,000, giving a free cash flow of -$32.97 million.

Operating Cash Flow	-32.80M
Capital Expenditures	-174,000
Free Cash Flow	-32.97M
FCF Per Share	-$0.39

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.76%
Shareholder Yield	-30.76%
Earnings Yield	-1.29%
FCF Yield	-2.79%

Analyst Forecast

The average price target for CRVS is $28.20, which is 100.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.20
Price Target Difference	100.28%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1